Arena Pharmaceuticals misses by $0.03, misses on revenue Arena Pharmaceuticals (NASDAQ:ARNA): Q4 EPS of -$0.15 misses by $0.03. Revenue of $9.2M (+41.1% Y/Y) misses by $1.16M.